3D-printed biodegradable breast implants for breast reconstruction
Official title: A Prospective, Multicenter, Controlled Clinical Study of 3D-printed Biodegradable Breast Implants for Breast Restoration
Run by Xijing Hospital · NCT06993714 · Data updated 2026-11-12
This study is testing if 3D-printed biodegradable breast implants can improve the look and safety of breast reconstruction for women with newly diagnosed breast cancer compared to traditional methods.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Xijing Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | January 1, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | June 6, 2025 |
| Trial ID | NCT06993714 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are female patients aged 18 to 70 with newly diagnosed primary breast cancer who are eligible for breast-conserving surgery or reconstruction.
✕Probably not a fit
Patients over 70 years old, those with stage IV metastatic breast cancer, or those with extensive lesions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the cosmetic effects and safety of breast reconstruction using 3D-printed biodegradable material implants in women with newly diagnosed primary breast cancer. Participants will be divided into three groups: one receiving the experimental biodegradable implants, and two control groups undergoing traditional breast-conserving surgery or silicone prosthesis reconstruction. The study aims to compare the quality of life and cosmetic outcomes between these methods. It also assesses the feasibility of using these innovative implants for patients who are not suitable for traditional surgical options.
Why it matters
Potential benefit: If successful, this approach could provide a more personalized and effective option for breast reconstruction, improving cosmetic outcomes and quality of life for patients.
How similar studies have gone: While the use of 3D printing in medical applications is growing, this specific approach to biodegradable breast implants is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients with newly diagnosed primary breast cancer, aged 18 to 70 years, confirmed by histopathology. * Willing to undergo breast-conserving surgery, concurrent silicone prosthesis breast reconstruction, or breast reconstruction with 3D-printed biodegradable material breast implants. * Having indications for subcutaneous glandectomy that preserves the nipples and areolas. * ECOG performance status score: 0-1. * If receiving neoadjuvant chemotherapy, the interval between chemotherapy completion and surgery is less than 8 weeks. * Good compliance with the planned treatment, ability to understand the study procedures, and willingness to sign the written informed consent form. Exclusion Criteria: * Age \> 70 years. * Newly diagnosed stage IV metastatic breast cancer. * Multicentric, extensive, or diffuse lesions; or inflammatory breast cancer. * Tumor invasion of the papillary areola complex. * Inability to accept/tolerate radiotherapy. * Breast cancer during pregnancy. * History of other malignant tumors within the past five years (except cured cervical carcinoma in situ and non-melanoma skin cancer). * Abnormal functions of vital organs (heart, lungs, liver, kidneys), poorly controlled diabetes, or other conditions that preclude surgery tolerance. * Patients deemed unsuitable for participation by the researchers.
Where it's running
-
Xijing hospital
Xi'an, Shaanxi, China Recruiting
Study contacts
- Study coordinator: Ju liang J L Zhang
- Email: vascularzhang@163.com
- Phone: 029-84775271
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EndoBreast: Feasibility and outcomes of nipple-sparing endoscopic mastectomy with immediate reconstruction
This observational study tests whether endoscopic nipple-sparing mastectomy with immediate reconstruction is feasible and acceptable for women at risk or with breast cancer.
-
Access My Breast Cancer Care App
A breast cancer care app is being tested to see if it helps patients navigate care, feel more satisfied, and reduce in-person visits.
-
Autologous Fat Grafting vs DIEP flap for reconstructed breast after radiation
This study tests whether autologous fat transfer can provide similar satisfaction and safety to the DIEP flap procedure for women needing breast reconstruction after mastectomy and radiation.
-
Prehabilitation with physiotherapy and mechanical stimulation before LD flap breast reconstruction
This study tests whether prehabilitation with physiotherapy and mechanostimulation improves shoulder pain and mobility for women undergoing breast reconstruction with a latissimus dorsi flap.
-
Fat grafting plus latissimus dorsi muscle flap for delayed breast reconstruction
This will try adding fat grafting to a latissimus dorsi muscle flap to rebuild breasts in women who previously had a mastectomy.
-
Hypofractionated radiotherapy after prosthetic breast reconstruction
This study tests whether a shorter, higher-dose radiotherapy course (HFRT) works as safely and effectively as the standard longer course (CFRT) for patients who had a mastectomy with implant reconstruction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.